|
|
Diabetes |
Non-diabetes |
|
Variables |
OR (95% CI) |
P value |
OR (95% CI) |
P value |
Model 1 |
Gender |
2.17 (1.16 ~ 4.09) |
0.016 |
3.70 (1.18 ~ 11.57) |
0.024 |
|
Age > 65y |
2.30 (1.35 ~ 3.92) |
0.002 |
3.79 (1.39 ~ 10.32) |
0.009 |
|
Non-hypertension |
2.05 (1.19 ~ 3.54) |
0.010 |
2.89 (1.07 ~ 7.81) |
0.037 |
|
Dyslipidemia |
1.95 (1.17 ~ 3.25) |
0.010 |
3.09 (1.17 ~ 8.18) |
0.023 |
|
Smoke |
2.25 (1.27 ~ 3.99) |
0.006 |
1.26 (0.46 ~ 3.47) |
0.657 |
|
Multivessel disease |
1.57 (0.79 ~ 3.10) |
0.197 |
2.46 (0.58 ~ 10.42) |
0.221 |
|
GFRMDRD< 90 mL/min/1.73m2 |
2.86 (1.71 ~ 4.79) |
< 0.001 |
3.24 (1.11 ~ 9.49) |
0.032 |
Model 2 |
Gender |
2.05 (1.10 ~ 3.81) |
0.024 |
3.07 (1.01 ~ 9.34) |
0.048 |
|
Age > 65y |
2.07 (1.20 ~ 3.57) |
0.009 |
3.00 (1.06 ~ 8.52) |
0.039 |
|
Non-hypertension |
2.03 (1.19 ~ 3.46) |
0.010 |
2.78 (1.04 ~ 7.47) |
0.042 |
|
Dyslipidemia |
2.04 (1.23 ~ 3.38) |
0.006 |
3.37 (1.28 ~ 8.86) |
0.014 |
|
Smoke |
2.35 (1.32 ~ 4.18) |
0.004 |
1.03 (0.39 ~ 2.74) |
0.953 |
|
Multivessel disease |
1.67 (0.86 ~ 3.27) |
0.131 |
2.86 (0.62 ~ 13.14) |
0.177 |
|
GFREPI< 90 mL/min/1.73m2 |
2.36 (1.35 ~ 4.14) |
0.003 |
4.50 (1.15 ~ 17.58) |
0.031 |
Model 3 |
Gender |
1.78 (0.92 ~ 3.44) |
0.089 |
3.73 (1.21 ~ 11.5) |
0.022 |
|
Age > 65y |
1.95 (1.11 ~ 3.42) |
0.020 |
3.88 (1.43 ~ 10.58) |
0.008 |
|
Non-hypertension |
2.40 (1.34 ~ 4.28) |
0.003 |
2.45 (0.93 ~ 6.47) |
0.070 |
|
Dyslipidemia |
2.04 (1.19 ~ 3.49) |
0.009 |
4.18 (1.56 ~ 11.16) |
0.004 |
|
Smoke |
2.47 (1.34 ~ 4.56) |
0.004 |
1.12 (0.42 ~ 3.01) |
0.820 |
|
Multivessel disease |
1.74 (0.87 ~ 3.51) |
0.120 |
2.58 (0.63 ~ 10.64) |
0.190 |
|
GFRCYS< 90 mL/min/1.73m2 |
6.21 (3.53 ~ 10.91) |
< 0.001 |
3.30 (1.20 ~ 9.04) |
0.020 |
GFRMDRD, GFREPI and GFRCYS are included in model 1, 2 and 3, respectively.
GFR, glomerular filtration rate |
|